Oral Lichen Planus and Systemical Oncological Comorbidities
NCT06449248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1517
Last updated 2024-06-07
Summary
Lichen planus (LP) is a chronic mucocutaneous inflammatory disease of unknown etiology.
In its oral variant, oral lichen planus (OLP) has a reported prevalence ranging from 0.5% to 2.2% in the general population. The disease typically occurs between the ages of 30 and 60. Although the pathogenetic mechanism and the triggering factor remain unknown, an immune-mediated pathogenesis and the role of factors such as stress, anxiety, diabetes, other autoimmune diseases, hypertension, intestinal pathologies, chronic liver diseases, hypercholesterolemia, infections have been hypothesized , contact with dental materials, tumors and genetic predisposition to cancer.
Oral lichen planus is one of the potentially malignant disorders, showing a malignant transformation rate of 1.4%.
A preliminary analysis conducted in our research center has shown a correlation between OLP and systemic tumors, both solid and haematological, involving areas not involved in lesions attributable to OLP.
According to these data, the objective of the study is to evaluate whether there is an association between OLP and peripheral tumors, both solid and haematological.
The primary objective will be to investigate the possible existence of a statistically significant association between OLP and the development of systemic oncological pathologies.
Secondary objective will be to investigate the existence of an association between the various forms of OLP and specific oncological pathologies and to evaluate whether the presence of other systemic pathologies and lifestyle factors (diabetes, hypertension, chronic liver disease, smoking, alcohol, infection by HPV, HCV, etc ...) could influence such association (primary outcome).
The objectives will be pursued through the analysis of data collected from the medical records of patients belonging to the General Dentistry and Orthodontic Outpatient Clinics at the "Agostino Gemelli" Teaching Hospital and in the Oral Pathology Outpatient Clinics of the other centers involved.
Conditions
- Oral Lichen Planus
Interventions
- OTHER
-
Checking of appropriateness of OLP diagnosis
The above mentioned interventions will be carried out through the accurate analysis of patients' clinical records
Sponsors & Collaborators
-
Catholic University of the Sacred Heart
lead OTHER
Principal Investigators
-
Romeo Patini, Univ. Res. · Catholic University of Sacred Heart - Rome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-02
- Primary Completion
- 2023-10-02
- Completion
- 2023-12-02
Countries
- Italy
Study Locations
More Related Trials
-
Molecular & Cellular Characterisation of Oral Lichen Planus
NCT04289233 ·Status: COMPLETED
-
Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus
NCT02421770 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus
NCT02587117 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
NCT05973097 ·Status: RECRUITING ·Phase: NA
-
Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other
NCT00484250 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus
NCT02443311 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Continuous Defocused CO2 Laser Vaporisation on the Histological Malignant Transformation of Erosive Oral Lichen Planus in Patients
NCT02154607 ·Status: COMPLETED ·Phase: NA
-
Assessing LncRNA DQ786243 and IL-17 Expression in Oral Lichen Planus: A Case Control Study
NCT04503824 ·Status: UNKNOWN
-
Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
NCT05330572 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen
NCT01061853 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus
NCT07131813 ·Status: RECRUITING ·Phase: PHASE4
-
Metagenomic Analysis of the Oral Microbiome in Patients With Oral Lichen Planus: A Pilot Study in the Turkish Population
NCT07137156 ·Status: COMPLETED
-
Study on Treatment for Patients With Symptomatic Oral Lichen Planus
NCT04718311 ·Status: COMPLETED ·Phase: NA
-
Association Between Oral Lichen Planus and Thyroid Disease
NCT06550154 ·Status: COMPLETED
-
Impact of Fluocinonide 0,05% in Oral Lichen Planus
NCT06135805 ·Status: COMPLETED ·Phase: NA
-
Treatmant of Oral Lichen Planus With Lycopene
NCT00656214 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus
NCT04976673 ·Status: COMPLETED ·Phase: PHASE2
-
Tacrolimus Ointment in Oral Lichen Planus
NCT01544842 ·Status: TERMINATED ·Phase: NA
-
Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers
NCT06332365 ·Status: COMPLETED ·Phase: NA
-
Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
NCT02453503 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Desmoglein-3 Autoantibodies in the Tissues of Oral Lichen Planus and Correlation with Disease Severity
NCT06652477 ·Status: NOT_YET_RECRUITING
-
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
NCT04364555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of add-on Apremilast Versus add-on Methotrexate in Patients With Oral Lichen Planus
NCT06260904 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus
NCT04652739 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream
NCT00321750 ·Status: TERMINATED ·Phase: PHASE2